Hugh James Freeman*

Department of Medicine (Gastroenterology), University of British Columbia, Vancouver, BC, Canada

*Corresponding Author: Hugh James Freeman, Department of Medicine (Gastroenterology), University of British Columbia, Vancouver, BC, Canada.

Received: January 05, 2023; Published: January 20, 2023

Abstract

Different intestinal malignancies develop in celiac disease, particularly lymphoma. In this study, the records of 154 patients with celiac disease followed during a 30 year period with an initial small bowel biopsy and a histopathological response to a gluten-free diet were retrospectively reviewed for development of adenocarcinoma. Four males were observed with a small bowel adenocarcinoma as well as 1 elderly female with colon cancer. Other sites, including esophagus, stomach, hepatobiliary tract and pancreas, had no adenocarcinomas detected. Patients with biopsy-defined celiac disease had an increased rate of small bowel adenocarcinoma, at least in males, but a reduced rate of colonic adenocarcinoma. These long-term clinical results from published studies in a well-defined population of celiac disease have important implications for further investigative endeavour related to celiac disease and intestinal malignancies.

Celiac Disease; Small Bowel Cancer; Colon Cancer; Epithelial Carcinogenesis; Gluten-free Diet; Cancer Enteropathy

References

1. Freeman HJ. “Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease”. Journal of Clinical Gastroenterology 38 (2004): 429-434.
2. Freeman HJ. “Adenocarcinoma of the small intestine in celiac disease over more than 30 years”. International Journal of Celiac Disease (2022).
3. Freeman HJ. “Colorectal cancer in biopsy-defined celiac disease seen over 30 years, rare, even in the elderly”. International Journal of Celiac Disease 9 (2021): 93-95.
4. Elfstrom P., et al. “Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease”. Clinical Gastroenterology and Hepatology 10 (2012): 30-36.
5. Ilus T., et al. “Incidence of malignancy in diagnosed celiac patients: a population-based estimate”. American Journal of Gastroenterology 109 (2014): 1471-1477.
6. Grainge MJ., et al. “The long-term risk of malignancy following a diagnosis of celiac disease or dermatitis herpetiformis: a cohort study”. Alimentary Pharmacology and Therapeutics 35 (2012): 730-739.
7. Anderson LA., et al. “Malignancy and mortality in a population-based cohort of patients with celiac disease or “gluten sensitivity”. World Journal of Gastroenterology 13 (2007): 146-151.
8. Silano M., et al. “Delayed diagnosis of celiac disease increases cancer risk”. BMC Gastroenterology 7 (2007): 8.
9. Green PH., et al. “Risk of malignancy in patients with celiac disease”. American Journal of Medicine 115 (2003): 191-195.
10. Askling J., et al. “Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis”. Gastroenterology 123 (2002): 1428-1435.
11. Caio G., et al. “Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features”. BMC Gastroenterology 19 (2019): 45.
12. Card TR., et al. “Risk of malignancy in diagnosed celiac disease: a 24-year prospective, population-based, cohort study”. Alimentary Pharmacology and Therapeutics 20 (2004): 769-775.
13. Pereyra L., et al. “Risk of colorectal neoplasia in patients with celiac disease: a multicenter study”. Journal of Crohn's and Colitis 7 (2013): e672-677.
14. Volta U., et al. “Low risk of colon cancer in patients with celiac disease”. Scandinavian Journal of Gastroenterology 49 (2014): 564-568.
15. Freeman HJ. “Drug-induced sprue-like intestinal disease”. International Journal of Celiac Disease 2 (2014): 49-53.
16. Freeman HJ. “Mucosal recovery and mucosal healing in biopsy-defined adult celiac disease”. International Journal of Celiac Disease 5 (2017): 14-18.
17. Emilsson L., et al. “Risk of small bowel adenocarcinoma , adenomas, and carcinoids in a nationwide cohort of individuals with celiac disease”. Gastroenterology 159 (2020): 1886-1694.
18. Freeman HJ and Berean KW. “Resolution of paraneoplastic collagenous enterocolitis”. Canadian Journal of Gastroenterology 20 (2006): 357-360.
19. Um CY., et al. “Association between grains, gluten and the risk of colorectal cancer in the Cancer Prevention Study-II Nutrition Cohort”. European Journal of Nutrition 59 (2020): 1739-1749.

Citation

Citation: Hugh James Freeman. “Intestinal Adenocarcinoma in Biopsy-Defined Celiac Disease". Acta Scientific Gastrointestinal Disorders 6.2 (2023): 16-18.

Copyright

Copyright: © 2022 Hugh James Freeman. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.